Spinal Epidural Lipomatosis in a Human Immunodeficiency Virus-Positive Patient Receiving Steroids and Protease Inhibitor Therapy

We describe a patient who became cushingoid as a result of receiving steroid therapy for thrombocytopenia purpura and who then developed spinal epidural lipomatosis 4 months after he started receiving ritonavir as part of his therapy for human immunodeficiency virus infection. We believe that ritonavir may have contributed to the development of epidural lipomatosis and that clinicians should be aware of this possible association.